Therapeutic targeting of TGF‐β in lung cancer

S Aftabi, A Barzegar Behrooz, M Cordani… - The FEBS …, 2024 - Wiley Online Library
Transforming growth factor‐β (TGF‐β) plays a complex role in lung cancer pathophysiology,
initially acting as a tumor suppressor by inhibiting early‐stage tumor growth. However, its …

Targeting pre-mRNA splicing in cancers: roles, inhibitors, and therapeutic opportunities

S Araki, M Ohori, M Yugami - Frontiers in Oncology, 2023 - frontiersin.org
Accumulating evidence has indicated that pre-mRNA splicing plays critical roles in a variety
of physiological processes, including development of multiple diseases. In particular …

SOX9 drives the epithelial–mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway

JQ Huang, FK Wei, XL Xu, SX Ye, JW Song… - Journal of translational …, 2019 - Springer
Background The distant metastasis of cancer cells is a risk factor for tumor lethality and poor
prognosis in non-small-cell lung carcinoma (NSCLC). Increased SOX9 expression has been …

Serine-arginine protein kinase 1 (SRPK1) promotes EGFR-TKI resistance by enhancing GSK3β Ser9 autophosphorylation independent of its kinase activity in non …

JQ Huang, LX Duan, QY Liu, HF Li, AP Hu, JW Song… - Oncogene, 2023 - nature.com
Resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) is a
major challenge for clinicians and patients with non-small cell lung cancer (NSCLC). Serine …

GOLPH3/CKAP4 promotes metastasis and tumorigenicity by enhancing the secretion of exosomal WNT3A in non-small-cell lung cancer

JW Song, J Zhu, XX Wu, T Tu, JQ Huang… - Cell death & …, 2021 - nature.com
Cancer metastasis is the main cause of mortality associated with non-small-cell lung cancer
(NSCLC), accounting for up to 70% of deaths among patients. The mechanisms underlying …

[HTML][HTML] Transcription factor AP-4 promotes tumorigenic capability and activates the Wnt/β-catenin pathway in hepatocellular carcinoma

J Song, C Xie, L Jiang, G Wu, J Zhu, S Zhang… - Theranostics, 2018 - ncbi.nlm.nih.gov
It has been reported that the transcription factor activating enhancer-binding protein 4
(TFAP4) is upregulated and associated with an aggressive phenotype in several cancers …

Oncogenic dysregulation of pre‐mRNA processing by protein kinases: challenges and therapeutic opportunities

C Naro, P Bielli, C Sette - The FEBS Journal, 2021 - Wiley Online Library
Alternative splicing and polyadenylation represent two major steps in pre‐mRNA‐
processing, which ensure proper gene expression and diversification of human …

NEAT1 acts as an inducer of cancer stem cell‐like phenotypes in NSCLC by inhibiting EGCG‐upregulated CTR1

P Jiang, A Chen, X Wu, M Zhou, I ul Haq… - Journal of cellular …, 2018 - Wiley Online Library
Long non‐coding RNAs (lncRNAs) play significant roles in the pathogenesis of various
cancers, including lung cancer. In this study, we aimed to investigate the biological function …

Combined inhibition of EZH2 and the autotaxin-LPA-LPA2 axis exerts synergistic antitumor effects on colon cancer cells

Y Long, Y Wang, M Qu, D Zhang, X Zhang, J Zhang - Cancer Letters, 2023 - Elsevier
Autotaxin (ATX), also known as ENPP2, is the key enzyme in lysophosphatidic acid (LPA)
production. LPA acts on its receptors on the cell membrane to promote cell proliferation and …

SRPK1 acetylation modulates alternative splicing to regulate cisplatin resistance in breast cancer cells

C Wang, Z Zhou, CS Subhramanyam, Q Cao… - Communications …, 2020 - nature.com
Cisplatin and other platinum-based compounds are frequently used to treat breast cancer,
but their utility is severely compromised by drug resistance. Many genes dictating drug …